Wei Cao
Directeur Général chez GRACELL BIOTECHNOLOGIES INC.
Postes actifs de Wei Cao
Sociétés | Poste | Début | Fin |
---|---|---|---|
GRACELL BIOTECHNOLOGIES INC. | Directeur Général | 01/05/2017 | - |
Président | 01/05/2017 | - | |
Fondateur | 01/05/2017 | - | |
Gracell Biotechnologies (Shanghai) Co., Ltd.
Gracell Biotechnologies (Shanghai) Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of Gracell Biotechnologies, Inc., Gracell Biotechnologies (Shanghai) Co., Ltd. is a clinical-stage biopharmaceutical company based in Shanghai, China. The Chinese company discovers and develops cellular therapeutics for patients suffering from cancer. The private company was founded in 2017 by Wei Cao, who has been the CEO since 2017. | Directeur/Membre du Conseil | - | - |
Directeur Général | - | - | |
Fondateur | 21/05/2017 | - | |
Gracell Biotechnologies (HK) Ltd. | Directeur Général | - | - |
Gracell Biopharmaceuticals, Inc. | Directeur Général | - | - |
Suzhou Gracell Biotechnologies Co., Ltd.
Suzhou Gracell Biotechnologies Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of Gracell Biotechnologies, Inc., Suzhou Gracell Biotechnologies Co., Ltd. is a private company that manufactures cancer cellular medicines. The company is based in Suzhou, China. The CEO of the Chinese company is Wei Cao. | Directeur Général | - | - |
Historique de carrière de Wei Cao
Anciens postes connus de Wei Cao
Sociétés | Poste | Début | Fin |
---|---|---|---|
CELLULAR BIOMEDICINE GROUP, INC. | Directeur/Membre du Conseil | 06/02/2013 | 01/05/2016 |
Directeur Général | 30/09/2013 | 06/02/2016 | |
Directeur des opérations | 06/02/2013 | 29/09/2013 | |
President | 06/02/2013 | 29/09/2013 | |
Cellular Biomedicine Group Ltd. | Directeur/Membre du Conseil | 01/08/2010 | 01/02/2013 |
Directeur des opérations | 01/08/2010 | 01/02/2013 | |
President | 01/08/2010 | 01/02/2013 |
Formation de Wei Cao
Medical College of Virginia | Doctorate Degree |
Harvard Medical School | Doctorate Degree |
Zhongshan Hospital Fudan University | Undergraduate Degree |
Statistiques
Internationale
Etats-Unis | 5 |
Chine | 4 |
Îles Cayman | 2 |
Opérationnelle
Chief Executive Officer | 6 |
Director/Board Member | 3 |
Chief Operating Officer | 2 |
Sectorielle
Health Technology | 5 |
Consumer Services | 4 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Entreprise privées | 7 |
---|---|
AbelZeta Pharma, Inc.
AbelZeta Pharma, Inc. BiotechnologyHealth Technology Cellular Biomedicine Group, Inc. is a holding company, which engages in the development of new treatments for cancerous and degenerative diseases utilizing proprietary cell-based technologies. It specializes in immune cell therapy. The company was founded in 2009 and is headquartered in Rockville, MD. | Health Technology |
Cellular Biomedicine Group Ltd. | |
Gracell Biotechnologies, Inc.
Gracell Biotechnologies, Inc. BiotechnologyHealth Technology Gracell Biotechnologies, Inc. is a clinical-stage biopharmaceutical company. It engages in the business of discovering and developing cell therapies to resolve industry challenges and fulfill unmet medical needs in the treatment of cancer. The company was founded by Wei Cao in May 2017 and is headquartered in Suzhou, China. | Health Technology |
Gracell Biotechnologies (Shanghai) Co., Ltd.
Gracell Biotechnologies (Shanghai) Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of Gracell Biotechnologies, Inc., Gracell Biotechnologies (Shanghai) Co., Ltd. is a clinical-stage biopharmaceutical company based in Shanghai, China. The Chinese company discovers and develops cellular therapeutics for patients suffering from cancer. The private company was founded in 2017 by Wei Cao, who has been the CEO since 2017. | Health Technology |
Gracell Biotechnologies (HK) Ltd. | |
Gracell Biopharmaceuticals, Inc. | |
Suzhou Gracell Biotechnologies Co., Ltd.
Suzhou Gracell Biotechnologies Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of Gracell Biotechnologies, Inc., Suzhou Gracell Biotechnologies Co., Ltd. is a private company that manufactures cancer cellular medicines. The company is based in Suzhou, China. The CEO of the Chinese company is Wei Cao. | Health Technology |